Pharmascience Inc. announced a major expansion of its sterile injectable manufacturing facility in Candiac, Québec, supported by partners with Innovation, Science and Economic Development Canada's Strategic Innovation Fund and by the Government of Québec through Investissement Québec.
As the largest Canadian-owned pharmaceutical company, Pharmascience is dedicated to building on its 40 years of expertise in pharmaceutical manufacturing by investing in growth in Québec. This major expansion project will allow Pharmascience to triple its injectable manufacturing capacity and has numerous benefits to the health of Canadians and to patients worldwide.
With the new plant expansion coming online in 2026, this project will:
- Build on strengths in R&D to attract more Contract Development and Manufacturing (CMO and CDMO) projects
- Improve Canada's domestic biomanufacturing capabilities and ability to meet pharmaceutical supply chain needs
- Increase manufacturing efficiency and result in faster response times to product shortages or urgent health challenges
- Fully implant Pharmascience as the Canadian leader in specialized, cytotoxic and high-potency injectable pharmaceutical manufacturing
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!